During the past decade, Duke University Medical Center: Transplantation conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Duke University Medical Center: Transplantation" #1 collaborator was "Clinical Trials in Organ Transplantation" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Rho Federal Systems Division, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Duke University Medical Center: Transplantation" are "Kidney Transplant Recipients" (1 trials), "Living-Donor Kidney Transplant" (1 trials) and "Lung Transplant" (1 trials). Many other conditions were trialed in "Duke University Medical Center: Transplantation" in a lesser frequency.

Most popular intervention types in "Duke University Medical Center: Transplantation" are "Biological" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Prednisone" (1 trials), "Procedure" (1 trials), "antithymocyte globulin (rabbit)" (1 trials), "belatacept" (1 trials) and "everolimus" (1 trials). Other intervention names were less common.

The vast majority of trials in "Duke University Medical Center: Transplantation" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Duke University Medical Center: Transplantation". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Duke University Medical Center: Transplantation, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Duke University Medical Center: Transplantation, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".